Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population
Vox Sanguinis · 2025
DOI: 10.1111/vox.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Emma Palfreyman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Australia. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Rh Isoimmunization, Polymorphism, Single Nucleotide. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Australian Government.
Abstract (Originalsprache)
Background and Objectives Two prior publications have identified a novel RHD variant in the Australian population with the pattern of single nucleotide variation (SNV) c.186G>T, c.410C>T, c.455A>C, c.602C>G, c.604G>A, c.733G>C, and a deletion or rearrangement with RHCE exon 9. The Australian Red Cross Lifeblood provides testing across Australia, and over a period of 8 years, this same RHD variant has been noted, with some cases presenting with allogeneic anti‐D. Materials and Methods Cases with the combination of SNVs were identified with the RHD BeadChip™ panel and massively parallel sequencing, and were collated. Clinical presentation, phenotype and the specificity of any antibodies were also reviewed.
Results
Twelve cases of the same pattern of SNV and exon change were identified. There was consistent finding of c.186G>T, c.410C>T, c.455A>C, c.602C>G, c.604G>A and c.733G>C, in association with RHCE replacement of exon 9. All cases except one were phenotypically D‐positive. Nine of 12 cases presented with anti‐D antibodies, often associated with pregnancy. Where ethnicity was reported, all individuals were of Australian Indigenous ethnicity.
Conclusion
This RHD variant is observed to date only in people of Australian Indigenous ethnicity and has clinical relevance. With wider knowledge of the variant, it is anticipated that there will be increased screening in this population, especially in women of childbearing age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Australia.
- Red Cell Reference, Australian Red Cross Lifeblood, Brisbane, Australia.
ORCID-Profile: Emma Palfreyman
Förderung
- Australian Government
Zitieren
APA
Palfreyman, E., Morrison, J., Wilson, B., Millard, G., Liew, Y. W., Powley, T., & Daly, J. (2025). Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population. Vox Sanguinis. https://doi.org/10.1111/vox.70113
Vancouver
Palfreyman E, Morrison J, Wilson B, Millard G, Liew YW, Powley T, et al. Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population. Vox Sanguinis. 2025. doi:10.1111/vox.70113
BibTeX
@article{Palfreyman2025,
author = {Palfreyman, Emma and Morrison, Jenny and Wilson, Brett and Millard, Glenda and Liew, Yew Wah and Powley, Tanya and Daly, James},
title = {Partial D variant with demonstrated risk of D alloimmunization in the Australian Indigenous population},
journal = {Vox Sanguinis},
year = {2025},
doi = {10.1111/vox.70113}
}
EUVIMED